Watch AVAH. Know when insiders buy.
One email the day a filing lands. Free.
| Period | Revenue | YoY | Gross margin | Operating income | Net income | YoY | EPS | Op. cash flow | Capex | Free cash flow | Filed |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Q2 2027 · Jul 4 | $670.5M | +13.7% | 32.6% | $80M | $40.3M | +49.1% | 0.18 | $80.9M | — | — | Aug 13 |
| Q1 2027 · Apr 4 | $647.9M | +15.9% | 31.7% | $69.3M | $41.7M | +702.1% | 0.19 | $4.3M | — | — | May 14 |
| Q4 2026 · Jan 3derived | $662.5M | +27.4% | 32.2% | $71M | $178.8M | +512.6% | 0.83 | $49.7M | — | — | Mar 19 |
| Q3 2026 · Sep 27 | $621.9M | +22.2% | 32.6% | $53.6M | $14.1M | — | 0.06 | $33.2M | — | — | Nov 6 |
| Q2 2026 · Jun 28 | $589.6M | +16.8% | 35.8% | $80M | $27M | +94.3% | 0.13 | $51.6M | — | — | Aug 13 |
| Q1 2026 · Mar 29 | $559.2M | +14.0% | 32.8% | $51.8M | $5.2M | — | 0.03 | −$8.6M | — | — | May 14 |
| Q4 2025 · Dec 28derived | $519.9M | +8.6% | 33.0% | $45.8M | $29.2M | — | 0.15 | $13.4M | — | — | Mar 19 |
| Q3 2025 · Sep 28 | $509M | +6.5% | 31.4% | $34M | −$42.8M | — | -0.22 | $29.4M | — | — | Nov 6 |
| Q2 2025 · Jun 29 | $505M | — | 31.3% | $37.1M | $13.9M | — | 0.07 | $1.8M | — | — | Aug 7 |
| Q1 2025 · Mar 30 | $490.7M | — | 29.7% | $22.9M | −$11.2M | — | -0.06 | −$12M | — | — | May 8 |
| Q4 2024 · Dec 30derived | $478.8M | — | 31.0% | $29.3M | −$25.7M | — | -0.14 | −$3M | — | — | Mar 13 |
| Q3 2024 · Sep 30 | $478M | — | 30.8% | −$76.4M | −$102.4M | — | -0.54 | $28.7M | — | — | Nov 7 |
| Year | Revenue | Gross margin | Operating income | Net income | Net margin | EPS | Op. cash flow | Capex | Free cash flow | Buybacks | Dividends paid |
|---|---|---|---|---|---|---|---|---|---|---|---|
| FY2026 · to Jan 3 | $2.4B | 33.3% | $256.5M | $225M | 9.2% | 1.05 | $125.9M | — | — | — | — |
| FY2025 · to Dec 28 | $2B | 31.4% | $139.8M | −$10.9M | -0.5% | -0.06 | $32.6M | — | — | — | — |
| FY2024 · to Dec 30 | $1.9B | 31.4% | $8.1M | −$134.5M | -7.1% | -0.71 | $22.7M | — | — | — | — |
| FY2023 · to Dec 31 | $1.8B | 30.9% | −$642.3M | −$662M | -37.0% | -3.57 | −$48.4M | — | — | — | — |
| FY2022 · to Jan 1 | $1.7B | 32.3% | −$36.1M | −$117M | -7.0% | -0.69 | −$11.3M | $15.9M | −$27.3M | — | — |
| FY2021 · to Jan 2 | $1.5B | 30.4% | −$3.5M | −$57M | -3.8% | -0.40 | $116.6M | $15.2M | $101.4M | — | — |
Every number comes from Aveanna Healthcare Holdings, Inc.'s own XBRL-tagged filings with the SEC, not a data vendor. Quarters marked derived are the fiscal year minus the three reported quarters, the same way every data provider computes Q4. Restated figures replace originals as later filings arrive.